CLSP Insider Trading Activity and SEC Form 4 Filings
CLSP insider trading summary
No open-market insider purchases or sales of Callisto Pharmaceuticals Inc (CLSP) have been reported on SEC Form 4 in the past 12 months.
Latest CLSP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 15, 2010 | Gabriel Cerrone | Director | Buy | $0 (12,935 @ $0.00) |
| Jan 19, 2010 | Christoph Bruening | Director | Sell | $123 (500 @ $0.24) |
| Jan 19, 2010 | Christoph Bruening | Director | Sell | $3K (14,500 @ $0.22) |
| Jan 13, 2010 | Christoph Bruening | Director | Sell | $1K (5,000 @ $0.24) |
| Jan 11, 2010 | Christoph Bruening | Director | Sell | $6K (25,000 @ $0.24) |
| Jan 8, 2010 | Christoph Bruening | Director | Sell | $5K (25,000 @ $0.21) |
| Jan 8, 2010 | Christoph Bruening | Director | Sell | $1K (5,000 @ $0.22) |
| Jan 8, 2010 | Christoph Bruening | Director | Sell | $6K (25,000 @ $0.24) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.